Comprehensive care for inflammatory bowel diseases (IBD)
We look forward to providing you with professional inflammatory bowel disease treatment in Dallas and Lubbock in a friendly and welcoming environment. We are a member of Baylor Scott & White Health. We work closely with Baylor Scott & White North Texas Colon and Rectal Associates to bring you comprehensive IBD care.
Baylor Scott & White has established agreements with several types of insurance to ensure your health needs are covered.
Aetna - (2)Medicare Advantage PlansAetna Signature Administrators
Blue Cross Blue Shield - (9)Blue Advantage HMOBlue Choice PPOBlue PremierBlue Premier Open Access HMOMedicare Advantage - OncorParPlanTraditionalIndemnityBlue Essentials
Cigna - (4)Children's Medical Center Employee PlanCity of Dallas Employee PlanLocalPlusOpen Access Plus
DFW ConnectedCare - (1)American Airlines Employee Benefit Plan
Healthscope - (2)DART ACO FlexDART ACO Flex Plus
HealthSmart - (2)ACCEL NetworkPreferred Network
Humana - (4)ChoiceCareHumana PreferredNational POSCommercial PPO Plans
Parkland Community Health Plan - (2)CHIP MedicaidHealthFirst Medicaid
Scott & White Health Plan - (16)HMO Network - Individual/FamilyEPO Network - Individual/Family2019 BSWH Employee Network - PPO & HSA2019 BSWH Employee Network - SEQA & EQASeniorCare Advantage HMOSeniorCare Advantage PPOHMO Network - GroupTRS - Active Care Participants NetworkPPO Network - GroupPPO Choice NetworkPPO Choice Preferred NetworkCigna PPO Network - Out-of-Area Member PlanTexas Statewide PPOPHCS/ARGUS - PPO Network - Out-of-Area Member PlanEPO Network - GroupMcLane Group Network
Superior Health Plan - (1)STAR+PLUS
Superior HealthPlan - (3)Medicare/Medicaid Dual Needs Plan: Advantage HMO SNPMedicare/Medicaid PlanSTAR+PLUS
UnitedHealth - (2)Nexus ACO OANexusACO R
University Mary Hardin-Baylor - (1)Employee Benefit Plan
We couldn’t find any results for ""
Baylor Scott & White Center for Inflammatory Bowel Diseases offers expertise and IDB treatment options conveniently located near you.
Crohn's disease is an inflammatory bowel disease (IBD) in which chronic inflammation causes damage to the gastrointestinal tract, typically the small intestine and/or the colon. There is no medical or surgical cure for Crohn's disease at the present time.Learn more about Crohn's disease
We specialize in the diagnosis and treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
We perform a variety of procedures to diagnosis and monitor the digestive tract:
- Capsule study
- Upper endoscopy (EGD)
In addition, we offer infusion therapies to manage symptoms:
Ulcerative colitis is an inflammatory bowel disease (IBD) in which inflammation causes damage to the large intestine—the colon and rectum. It is a chronic disease without medical cure at the present time.Learn more about ulcerative colitis
Baylor Scott & White Health is pleased to offer you multiple options to pay your bill. View our guide to understand your Baylor Scott & White billing statement.
We offer two online payment options:
- Make a one-time payment without registering by selecting the "Pay a Bill as a Guest" option.
- Enroll or login to your MyBSWHealth account to view account balances and statements, setup a payment plan or enroll in paperless statements.
Other payment options:
Pay by mail
To ensure that your payment is properly applied to your account, detach the slip from your Baylor Scott & White billing statement and return the slip with your payment. If paying by check or money order, be sure to include your account number on the check or money order.
Please mail payment to the address listed on your statement.
Pay by phone
Payments to HTPN can be made over the phone with our automated phone payment system 24 hours a day, seven days a week. All payments made via the automated phone payment system will post the next business day. Please call 1.866.377.1650.
If you need to speak to someone about a bill from a Baylor Scott & White Hospital, our Customer Service department is available to take payments over the phone from Monday through Friday from 8:00 AM - 5:00 PM and can be reached at 1.800.994.0371.
Pay in person
Payments can be made in person at the facility where you received services.
At Baylor Scott & White Health, we want to be a resource for you and your family. Our team of customer service representatives and financial counselors are here to help you find financial solutions that can help cover your cost of care. We encourage you to speak to a member of our team at any time before, during or after care is received.
You may bring these to your appointment.
We need this form as soon as possible in order to request your medical records from other providers involved in your care. If our office does not receive this form in a timely manner, then our office will be unable to obtain medical records relating to your condition. In order for your appointment to run smoothly and in a timely manner we require having medical records prior to appointment. If we do not receive your release of information in a timely manner we will, unfortunately, have to reschedule your appointment.
The assessment is detailed, but it is so we can provide the best care to you. Please take your time filling this form out, and give us as much detail as you need to. Themistocles Dassopoulos, MD, requires that the health assessment is done prior to you coming in for your appointment. Dr. Dassopoulos will evaluate your history and present-day symptoms to prepare for your upcoming visit.
- Capsule study prep
- Colonoscopy prep
- How to take Prepopik for colonoscopy
- How to take MoviPrep for colonoscopy
- Upper endoscopy (EGD) prep
Where to go for procedures
Truett Hospital, First Floor
Baylor University Medical Center Campus
Crohn's Disease Life Expectancy
Dr. Dassopoulos was recently interviewed by US News and World Report on the topic of mortality of Crohn's disease. Dr. Dassopoulos emphasized that the life span of individuals suffering from Crohn's disease is essentially the same as that of the general population.
IBS and IBD: More Than Just Tummy Trouble
Listen to Dr. Dassopoulos on KERA, Vital Signs series, explain the differences between IBS and IBD.
Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 1)
Dr Dassopoulos discusses the differences between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
Watch the video
Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 2)
Dr. Dassopoulos educates on the most common symptoms, causes and therapies of IBD.
Watch the video
Pharmaceutical companies offer patient assistance programs which provide assistance to those who need financial support in paying for their medication. Please note, these programs usually apply to those who are uninsured. To find information on various patient assistance programs providing assistance for specific medication, the links are:
BSWH patient education
Baylor Scott & White Center for Inflammatory Bowel Diseases conducts a number of ongoing research studies that may benefit you, including clinical trials of medications that hold the promise of improving the health of patients with ulcerative colitis or Crohn's disease. To learn more, contact the Dallas clinical trials office at 214.818.9688.
The Center for IBD Research performs cutting-edge, impactful translational and basic research on IBD to improve our understanding of the disease and develop better treatments.
- Inflammatory bowel diseases and autophagy
- Crohn’s disease of the ileum
- Barrier function of the intestinal epithelium
- Colitis-associated colorectal cancer
- Intestinal stem cell responses to inflammation and diet
Dr. Theiss published an article on factors driving inflammation progression to cancer.
- Arianne L. Theiss, PhD, Research Director
- Themistocles Dassopoulos, MD, Medical Director
- Jie Han, MD, MS
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn’s Disease who have failed anti-TNF therapy
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease.
A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis (UC)
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis